In conclusion, this study crystallizes the role of lncRNAs XIST and TSIX as stable non-invasive immune biomarkers better tolerated by patients compared to conventional biopsies with a potential role in reflecting the evaded immune status of BC patients. This evidence concerns the gene XIST and breast cancer.